Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 5/20 | 0.55 |
| ▸ | ABL1 | P00519 | 7/20 | 0.54 |
| ▸ | TEK | Q02763 | 3/20 | 0.54 |
| ▸ | NTRK1 | P04629 | 2/20 | 0.54 |
| ▸ | NTRK2 | Q16620 | 2/20 | 0.54 |
| ▸ | CDK8 | P49336 | 4/20 | 0.52 |
| ▸ | CCNC | P24863 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 4/20 | 0.51 |
| ▸ | MAP3K7 | O43318 | 2/20 | 0.49 |
| ▸ | MAP4K2 | Q12851 | 2/20 | 0.49 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.49 |
| ▸ | MAP3K20 | Q9NYL2 | 2/20 | 0.49 |
| ▸ | MKNK2 | Q9HBH9 | 5/20 | 0.48 |
| ▸ | MKNK1 | Q9BUB5 | 4/20 | 0.48 |
| ▸ | BRAF | P15056 | 3/20 | 0.48 |
| ▸ | CDK2 | P24941 | 3/20 | 0.48 |
| ▸ | BCR | P11274 | 3/20 | 0.48 |
| ▸ | SRC | P12931 | 3/20 | 0.48 |
| ▸ | EGFR | P00533 | 2/20 | 0.48 |
| ▸ | STK10 | O94804 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23068654 | 1.00 | RET (0.55) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL23068639 | 0.95 | EGFR (0.54) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL29629211 | 0.95 | EGFR (0.54) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL23068622 | 0.94 | CDK8 (0.54) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL29629236 | 0.94 | CDK8 (0.54) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL23068681 | 0.93 | RET (0.60) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL29629238 | 0.93 | RET (0.60) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL22684882 | 0.93 | ABL1 (0.47) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL29629233 | 0.93 | ABL1 (0.47) | RETABL1TEKNTRK1NTRK2 | |
| SCHEMBL23068679 | 0.93 | CDK8 (0.52) | RETABL1TEKNTRK1NTRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111757881-B | 5- (Pyrimidin-4-yl) thiazol-2-yl urea derivatives as therapeutic agents | 澳升医药公司 | 2024-05-07 | — | — | CN | claimed |
| CN-111757881-B | 5- (Pyrimidin-4-yl) thiazol-2-yl urea derivatives as therapeutic agents | 澳升医药公司 | 2024-05-07 | — | — | CN | disclosed |
| US-20230092876-A1 | 5-(PYRIMIDIN-4-YL)THIAZOL-2-YL UREA DERIVATIVES AS THERAPEUTIC AGENTS | AUCENTRA THERAPEUTICS PTY LTD (AU) | 2023-03-23 | — | — | US | disclosed |
| US-11325900-B2 | 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents | AUCENTRA HOLDINGS PTY LTD (AU) | 2022-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230092876-A1 | 5-(PYRIMIDIN-4-YL)THIAZOL-2-YL UREA DERIVATIVES AS THERAPEUTIC AGENTS | CDK8, CDK18, CDK9 | RET 494/4885ABL1 268/4885TEK 2224/4885 |
| US-11325900-B2 | 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents | CDK8, CDK18, CDK9 | RET 494/4885ABL1 268/4885TEK 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.